Cell : Actualité Cell en direct - P1 | Bourse Reflex
Accueil > Tags > Cell

  • Toutes les actualités en rapport avec « Cell »

02/05 07:30 Cell - ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER

26/04 18:00 Cell - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

23/04 07:30 Cell - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:05 Cell - 19/04/2018 - Exercise of the make whole call on 100% of the 2020 notes of 500 million euros

19/04 18:00 Cell - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

12/04 21:25 Cell - 12/04/2018 - Successful pricing of a new 10-year bond issue of EUR 700 million

11/04 10:10 Cell - 11/04/2018 - Infra Park's BBB rating confirmed with stable outlook revised in view of its financing strategy

09/04 18:00 Cell - Quantum Genomics strengthens its governance

09/04 18:00 Cell - Quantum Genomics renforce sa gouvernance

04/04 11:45 Cell - INFRA PARK TO OFFER NEW BONDS

21/03 07:30 Cell - THERANEXUS ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS PART OF THE DEVELOPMENT OF ITS DRUG CANDIDATES THN201 AND THN101

15/03 07:30 Cell - THERANEXUS AND THE COLLEGE DE FRANCE SIGN A RESEARCH AGREEMENT ON ASTROCYTE-NEURON INTERACTIONS

28/09 07:30 Cell - Theranexus files its registration document as part of its planned Initial Public Offering (IPO) on the Euronext Growth market in Paris

14/03 18:00 Cell - Quantum Genomics announces positive data from new preclinical studies with QGC001

08/03 18:00 Cell - Altamir concludes a record year for divestments and value creation in the portfolio

01/06 19:00 Cell - GENTICEL ANNOUNCES PUBLICATION IN 'CLINICAL CANCER RESEARCH' OF PHASE 1 TRIAL RESULTS SUPPORTING SAFETY, TOLERABILITY AND IMMUNOGENICITY OF GTL001

14/03 07:00 Cell - GENTICEL ANNOUNCES 2015 ANNUAL RESULTS AND STRATEGIC UPDATE FOR 2016

05/01 19:00 Cell - Genticel appoints Rémi Palmantier, PhD, as Chief Scientific Officer to accelerate its development

16/11 18:30 Cell - Q3 2015 Financial information

19/10 14:00 Cell - Brightpoint Announces Agreement With Microsoft to Launch Windows(R) Phone Online Shop in the Middle East and Africa